クローン病治療薬の世界市場レポート：動向、予測、競合分析（～2031年）

クローン病治療薬の世界市場の将来は、小腸市場と大腸市場に機会があり、有望視されています。世界のクローン病治療薬の市場規模は、2025年～2031年にCAGR3.8%で成長すると予測されます。この市場の主な促進要因は、クローン病の有病率が世界的に上昇し、治療に対する需要が高まっていること、より効果的な治療につながる医薬品の開発が進んでいること、治療オプションの採用を促進する認知度や診断の向上が進んでいることです。

• Lucintelの予測では、タイプ別では、免疫調節薬が標的への作用と採用の増加により、予測期間中に高い成長が見込まれます。
• 用途別では、クローン病では小腸の病変が多いことから、小腸が最も高い成長が見込まれます。
• 地域別では、北米がヘルスケアのインフラと認知度の高さから予測期間中に最も高い成長を遂げると予想されます。

クローン病治療薬市場の新たな動向

生物学的治療、精密医療、新たな治療オプションなどの新たな動向がクローン病治療薬市場を変化させています。これらの新たな動向は、患者の転帰の改善、治療の最適化、治療薬へのアクセスの拡大という観点から市場を形成しています。

• 生物学的製剤：抗TNF阻害剤、抗インテグリン療法、インターロイキン阻害剤は、中等度から重度のクローン病の治療薬として急成長しています。生物学的製剤は従来の薬剤よりも特異的で強力であるため、副作用が少なく、疾患コントロールが改善します。生物学的製剤は市場の成長も牽引しています。
• 経口薬：クローン病に対する経口治療の導入は、より便利な選択肢を提供することで患者の治療に革命をもたらしています。JAK阻害剤のように経口投与が可能な薬剤は注射の必要性を減らし、患者のコンプライアンスとQOLを向上させます。この動向は、特に管理しやすい治療レジメンを求める患者の間で、市場成長の原動力となる可能性が高いです。
• 個別化医療：精密医療は、患者の遺伝子プロファイルや疾患の特徴に基づいて治療動向を調整する新たなトレンドです。特定のバイオマーカーを特定することで、医師はクローン病の治療を個別化することができ、治療成績の向上と副作用の軽減につながります。このアプローチはクローン病の治療レジメンに大きな影響を与える可能性があります。
• バイオシミラー：生物学的製剤の使用拡大に伴い、バイオシミラーの開発がクローン病治療の費用対効果に優れた解決策として浮上してきました。先発品の生物学的製剤に代わるバイオシミラー製剤はより手頃な価格であり、特にヘルスケア予算が限られている新興市場において、患者の質の高い治療へのアクセスを改善することが期待されています。
• 遠隔医療と遠隔モニタリング：遠隔医療と遠隔患者モニタリングはクローン病治療市場で普及しつつあります。これらの技術により、ヘルスケア提供者は遠隔地から患者の症状や治療アドヒアランスを追跡することが可能となり、疾病管理が改善されます。遠隔医療は、より良いフォローアップケアと治療レジメンのタイムリーな調整を可能にし、患者の転帰を向上させます。

生物学的製剤、経口薬、個別化医療、バイオシミラー、遠隔医療などの新たな動向がクローン病治療薬市場に大きな変化をもたらしています。これらの技術革新は、治療の選択肢を増やし、患者の転帰を改善し、治療へのアクセスを拡大し、クローン病の管理方法を世界的に再構築しています。

クローン病治療薬市場の最近の発展

クローン病治療薬市場は、生物学的製剤、経口治療薬、診断技術の革新に牽引され、最近の顕著な動向を示しています。これらの発展は、より効果的な疾患管理に貢献し、患者と製薬企業の双方に大きな機会をもたらしています。

• 新しい生物学的製剤の承認：いくつかの新しい生物学的製剤がクローン病に対して承認され、中等度から重度のクローン病患者により的を絞った効果的な治療が提供されるようになりました。これらの薬剤は特定の炎症経路を標的として作用するため、従来の治療法と比較して、より良好な病勢コントロールと少ない副作用をもたらします。
• 経口JAK阻害剤の導入：クローン病に対する経口ヤヌスキナーゼ（JAK）阻害薬の承認と導入は、治療の状況を大きく変えるものでした。これらの経口薬は注射剤である生物学的製剤に代わるもので、患者にとって治療がより簡単で便利になり、その結果、アドヒアランスと治療成績全体が向上しました。
• バイオシミラーとコスト削減：バイオシミラーの開発により、生物学的製剤による治療がより安価になり、患者にとって利用しやすくなりました。バイオシミラーの導入は、コスト負担を軽減し、より多くの患者が生物学的製剤による治療の恩恵を受けられるようにすることで、クローン病治療市場の拡大に貢献しています。
• 高度な診断ツール：バイオマーカーや高度な画像診断技術などの新しい診断ツールにより、クローン病の診断とモニタリングが向上しています。これらの進歩により、疾患の早期発見と進行の正確なモニタリングが可能となり、治療成績の向上と個別化治療につながります。
• 個別化医療への注力：個人の遺伝的体質や疾患プロファイルに合わせた治療を行う個別化医療は、クローン病の治療において勢いを増しています。治療方針の決定に遺伝子検査を活用することで、治療成績の向上と副作用の軽減が期待できます。

新しい生物学的製剤、経口JAK阻害剤、バイオシミラー、高度診断薬、個別化医療など、クローン病治療薬市場における最近の動向は、治療の展望を再構築しつつあります。これらの技術革新は患者ケアを改善し、クローン病の管理により的を絞った、より便利で費用対効果の高い選択肢を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 クローン病治療薬市場：タイプ別

• 概要
• タイプ別の魅力分析
• アミノサリチル酸塩：動向と予測（2019年～2031年）
• コルチコステロイド：動向と予測（2019年～2031年）
• 免疫調節薬：動向と予測（2019年～2031年）
• 抗生物質：動向と予測（2019年～2031年）

第5章 クローン病治療薬市場：用途別

• 概要
• 用途別の魅力分析
• 小腸：動向と予測（2019年～2031年）
• 大腸：動向と予測（2019年～2031年）

第6章 地域分析

• 概要
• クローン病治療薬市場（地域別）

第7章 北米のクローン病治療薬市場

• 概要
• 北米のクローン病治療薬市場（タイプ別）
• 北米のクローン病治療薬市場（用途別）
• 米国のクローン病治療薬市場
• メキシコのクローン病治療薬市場
• カナダのクローン病治療薬市場

第8章 欧州のクローン病治療薬市場

• 概要
• 欧州のクローン病治療薬市場（タイプ別）
• 欧州のクローン病治療薬市場（用途別）
• ドイツのクローン病治療薬市場
• フランスのクローン病治療薬市場
• スペインのクローン病治療薬市場
• イタリアのクローン病治療薬市場
• 英国のクローン病治療薬市場

第9章 アジア太平洋のクローン病治療薬市場

• 概要
• アジア太平洋のクローン病治療薬市場（タイプ別）
• アジア太平洋のクローン病治療薬市場（用途別）
• 日本のクローン病治療薬市場
• インドのクローン病治療薬市場
• 中国のクローン病治療薬市場
• 韓国のクローン病治療薬市場
• インドネシアのクローン病治療薬市場

第10章 世界のその他地域のクローン病治療薬市場

• 概要
• 世界のその他地域のクローン病治療薬市場（タイプ別）
• 世界のその他地域のクローン病治療薬市場（用途別）
• 中東のクローン病治療薬市場
• 南米のクローン病治療薬市場
• アフリカのクローン病治療薬市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • タイプ別の成長機会
  • 用途別の成長機会
• クローン病治療薬市場における新たな動向
• 戦略分析
  • 新製品開発
  • 認証とライセンシング
  • 合併、買収、契約、提携、合弁事業

第13章 バリューチェーンにおける主要企業プロファイル

• 競合分析
• Biogen
• UCB
• Boehringer
• AstraZeneca
• AbbVie

第14章 付録

• 図一覧
• 表一覧
• 調査手法
• 免責事項
• 著作権
• 略語および技術単位
• Lucintelについて
• お問い合わせ

List of Figures

• Figure 1.1: Trends and Forecast for the Global Crohn'S Disease Treatment Drug Market
• Figure 2.1: Usage of Crohn'S Disease Treatment Drug Market
• Figure 2.2: Classification of the Global Crohn'S Disease Treatment Drug Market
• Figure 2.3: Supply Chain of the Global Crohn'S Disease Treatment Drug Market
• Figure 2.4: Driver and Challenges of the Crohn'S Disease Treatment Drug Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Type
• Figure 4.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Type
• Figure 4.4: Trends and Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 4.5: Trends and Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 4.6: Trends and Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 4.7: Trends and Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 5.1: Global Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Application
• Figure 5.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Application
• Figure 5.4: Trends and Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 5.5: Trends and Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 6.1: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 7.2: North American Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
• Figure 7.5: North American Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 8.2: European Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
• Figure 8.5: European Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 9.2: APAC Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Crohn'S Disease Treatment Drug Market (2019-2031)
• Figure 10.2: ROW Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Crohn'S Disease Treatment Drug Market
• Figure 11.2: Market Share (%) of Top Players in the Global Crohn'S Disease Treatment Drug Market (2024)
• Figure 12.1: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Type
• Figure 12.2: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Application
• Figure 12.3: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Region
• Figure 12.4: Emerging Trends in the Global Crohn'S Disease Treatment Drug Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Crohn'S Disease Treatment Drug Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Crohn'S Disease Treatment Drug Market by Region
• Table 1.3: Global Crohn'S Disease Treatment Drug Market Parameters and Attributes
• Table 3.1: Trends of the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 3.2: Forecast for the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 4.4: Trends of Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 4.5: Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 4.6: Trends of Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 4.7: Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 4.8: Trends of Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 4.9: Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 4.10: Trends of Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 4.11: Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 5.4: Trends of Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 5.5: Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 5.6: Trends of Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 5.7: Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 7.1: Trends of the North American Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 7.2: Forecast for the North American Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 8.1: Trends of the European Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 8.2: Forecast for the European Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 9.1: Trends of the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 9.2: Forecast for the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 10.1: Trends of the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 10.2: Forecast for the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market (2019-2031)
• Table 11.1: Product Mapping of Crohn'S Disease Treatment Drug Suppliers Based on Segments
• Table 11.2: Operational Integration of Crohn'S Disease Treatment Drug Manufacturers
• Table 11.3: Rankings of Suppliers Based on Crohn'S Disease Treatment Drug Revenue
• Table 12.1: New Product Launches by Major Crohn'S Disease Treatment Drug Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Crohn'S Disease Treatment Drug Market

The future of the global Crohn's disease treatment drug market looks promising with opportunities in the small intestine and large intestine markets. The global Crohn's disease treatment drug market is expected to grow with a CAGR of 3.8% from 2025 to 2031. The major drivers for this market are the rising prevalence of Crohn's disease globally, which increases demand for treatment, advancements in drug development that lead to more effective therapies, and increased awareness and diagnosis that drive higher adoption of treatment options.

• Lucintel forecasts that, within the type category, immunomodulators are expected to witness higher growth over the forecast period due to their targeted action and increasing adoption.
• Within the application category, the small intestine is expected to witness the highest growth due to more frequent involvement in Crohn's disease.
• In terms of region, North America is expected to witness the highest growth over the forecast period due to advanced healthcare infrastructure and awareness.

Emerging Trends in the Crohn's Disease Treatment Drug Market

Emerging trends such as biologic therapies, precision medicine, and new treatment options are changing the Crohn's disease treatment drug market. These emerging trends are shaping the market in terms of improving patient outcomes, optimizing treatments, and expanding access to medications.

• Biologics: Anti-TNF inhibitors, anti-integrin therapies, and interleukin inhibitors are a fast-growing treatment avenue for moderate to severe Crohn's disease. Biologics are more specific and more potent than conventional drugs; thus, they help patients with fewer side effects and improved disease control. Biologic drugs have also driven the growth of the market.
• Oral Medications: The introduction of oral treatments for Crohn's disease is revolutionizing patient care by offering more convenient options. Drugs like JAK inhibitors, which can be taken orally, reduce the need for injections, improving patient compliance and quality of life. This trend is likely to drive market growth, especially among patients seeking more manageable treatment regimens.
• Personalized Medicine: Precision medicine is an emerging trend that tailors treatments based on a patient's genetic profile and disease characteristics. By identifying specific biomarkers, doctors can personalize treatments for Crohn's disease, leading to better outcomes and fewer side effects. This approach has the potential to significantly impact treatment regimens for Crohn's disease.
• Biosimilars: With the growing use of biologics, the development of biosimilars has emerged as a cost-effective solution for managing Crohn's disease. These alternatives to branded biologics are more affordable and are expected to improve access to high-quality treatments for patients, particularly in emerging markets with limited healthcare budgets.
• Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring are gaining traction in the Crohn's disease treatment market. These technologies enable healthcare providers to track patient symptoms and treatment adherence from a distance, improving the management of the disease. Telemedicine allows for better follow-up care and timely adjustments to treatment regimens, enhancing patient outcomes.

Emerging trends such as biologic therapies, oral medications, personalized medicine, biosimilars, and telemedicine are driving significant changes in the Crohn's disease treatment drug market. These innovations are enhancing treatment options, improving patient outcomes, and expanding access to care, reshaping how Crohn's disease is managed globally.

Recent Developments in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market has seen notable developments in recent years, driven by innovations in biologics, oral therapies, and diagnostic techniques. These developments have contributed to more effective disease management and offer significant opportunities for both patients and pharmaceutical companies.

• Approval of New Biologic Therapies: Several new biologic drugs have been approved for Crohn's disease, offering more targeted and effective treatments for patients with moderate-to-severe disease. These drugs work by targeting specific inflammatory pathways, resulting in better disease control and fewer side effects compared to traditional therapies.
• Introduction of Oral JAK Inhibitors: The approval and introduction of oral Janus kinase (JAK) inhibitors for Crohn's disease have been a game-changer in the treatment landscape. These oral medications offer an alternative to injectable biologics, making treatment easier and more convenient for patients, thus improving adherence and overall treatment outcomes.
• Biosimilars and Cost Reduction: The development of biosimilars has made biologic treatments more affordable, leading to greater accessibility for patients. The introduction of biosimilars is helping to expand the market for Crohn's disease treatments by reducing the cost burden and allowing more patients to benefit from biologic therapies.
• Advanced Diagnostic Tools: New diagnostic tools, such as biomarkers and advanced imaging techniques, are improving the diagnosis and monitoring of Crohn's disease. These advancements allow for earlier detection and more accurate monitoring of disease progression, leading to better treatment outcomes and personalized care.
• Focus on Personalized Medicine: Personalized medicine, which tailors treatments to an individual's genetic makeup and disease profile, is gaining momentum in the management of Crohn's disease. The use of genetic testing to guide treatment decisions is expected to improve therapeutic outcomes and reduce side effects, as therapies are better matched to the patient's specific needs.

The recent developments in the Crohn's disease treatment drug market, including new biologic therapies, oral JAK inhibitors, biosimilars, advanced diagnostics, and personalized medicine, are reshaping the treatment landscape. These innovations are improving patient care and offering more targeted, convenient, and cost-effective options for managing Crohn's disease.

Strategic Growth Opportunities in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market presents several strategic growth opportunities, particularly through innovations in biologic therapies, oral medications, and emerging markets. Pharmaceutical companies are looking to expand their portfolios and reach new patient populations by addressing unmet medical needs in Crohn's disease treatment.

• Expansion of Biologic Therapies: As biologic therapies continue to show strong efficacy in treating Crohn's disease, there is significant growth potential in developing and marketing new biologics. Companies can capitalize on this opportunity by exploring new targets in immune pathways to develop next-generation therapies that provide even better outcomes for patients.
• Biosimilars: The biosimilars market is growing, and this is a cost-effective opportunity in the Crohn's disease treatment market. Pharmaceutical companies can take advantage of the patent expiration of biologics to develop biosimilars, thereby improving patient access to treatment and expanding the market in both developed and emerging regions.
• Introduction of Oral Treatment Options: The shift toward oral treatments for Crohn's disease presents a strategic growth opportunity for pharmaceutical companies. With oral JAK inhibitors and other innovative treatments, companies can offer more convenient therapies that improve patient adherence, leading to increased market share and patient satisfaction.
• Expanding into Emerging Markets: With the increasing prevalence of Crohn's disease in emerging markets like China and India, there is a significant opportunity to expand treatment access. Pharmaceutical companies can capitalize on this by introducing affordable therapies and leveraging local partnerships to improve the availability of Crohn's disease treatments.
• Personalized Medicine and Genetic Testing: Personalized medicine offers an exciting growth opportunity by tailoring treatments based on genetic profiling. Pharmaceutical companies can invest in genetic testing platforms and companion diagnostics to optimize treatment regimens for Crohn's disease, providing more effective and individualized care.

Strategic growth opportunities in the Crohn's disease treatment drug market lie in biologics, biosimilars, oral therapies, expanding into emerging markets, and embracing personalized medicine. These opportunities provide companies with avenues to innovate, enhance patient care, and tap into new patient populations, driving growth in the market.

Crohn's Disease Treatment Drug Market Driver and Challenges

The Crohn's disease treatment drug market is influenced by various drivers and challenges, including advancements in medical technology, patient access, and regulatory dynamics. Understanding these factors is essential for stakeholders aiming to navigate the market's evolving landscape.

The factors responsible for driving the Crohn's disease treatment drug market include:

1. Technological Advancements in Biologic Therapies: Advances in biologic therapies, including monoclonal antibodies and anti-TNF agents, have significantly improved the treatment of Crohn's disease. These innovations allow for more targeted treatment, reducing inflammation and enhancing patient outcomes.

2. Increasing Awareness of Crohn's Disease: Growing awareness of Crohn's disease, both among patients and healthcare providers, is driving demand for new treatments. Early diagnosis and intervention are becoming more common, leading to improved patient care and greater use of advanced therapies.

3. Government and Healthcare Investments: Governments and healthcare organizations are increasingly investing in the treatment of chronic conditions like Crohn's disease. These investments support research and the availability of effective medications, helping to drive market growth and improve patient access to therapies.

4. Rising Prevalence of Crohn's Disease: The rising prevalence of Crohn's disease globally is increasing the demand for effective treatments. This trend is pushing pharmaceutical companies to develop new therapies and expand their portfolios to meet the needs of a growing patient population.

5. Regulatory Support for Drug Approvals: Favorable regulatory environments, especially in developed countries like the U.S. and Germany, are expediting the approval process for new Crohn's disease treatments. Faster approvals are allowing innovative therapies to reach the market sooner, benefiting patients in need.

Challenges in the Crohn's disease treatment drug market are:

1. High Treatment Costs: The high cost of biologics and advanced therapies remains a significant challenge, particularly for patients in low-income regions. The cost of these treatments can limit access to care and slow market growth.

2. Access to Treatment in Developing Regions: Limited access to treatment in developing regions, especially for advanced therapies like biologics, poses a challenge. This is due to both financial barriers and a lack of healthcare infrastructure.

3. Side Effects and Treatment Resistance: Some patients experience side effects from biologic therapies, and in some cases, they may develop resistance to these treatments. Managing these side effects and finding alternative therapies is an ongoing challenge.

The drivers, including technological advancements, increased awareness, and regulatory support, are fueling the growth of the Crohn's disease treatment drug market. However, challenges such as high costs, limited access to treatment, and side effects need to be addressed to fully optimize market potential.

List of Crohn's Disease Treatment Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, Crohn's disease treatment drug companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the Crohn's disease treatment drug companies profiled in this report include:

• Biogen
• UCB
• Boehringer
• AstraZeneca
• AbbVie

Crohn's Disease Treatment Drug Market by Segment

The study includes a forecast for the global Crohn's disease treatment drug market by type, application, and region.

Crohn's Disease Treatment Drug Market by Type [Value from 2019 to 2031]:

• Aminosalicylates
• Corticosteroids
• Immunomodulators
• Antibiotics

Crohn's Disease Treatment Drug Market by Application [Value from 2019 to 2031]:

• Small Intestine
• Large Intestine

Crohn's Disease Treatment Drug Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Crohn's Disease Treatment Drug Market

The Crohn's Disease Treatment Drug market is dynamic with significant strides in medication and therapies to handle this chronic inflammatory bowel disease. As the cases of Crohn's disease grow worldwide, nations such as the United States, China, Germany, India, and Japan have made progress toward better treatment alternatives, which eventually led to successful patient outcomes and further growth of the market.

• United States: The United States is the leader in Crohn's disease management, with continually increased application of biologic therapies like anti-TNF and anti-integrin antibodies. Novel drugs, including oral agents and Janus kinase (JAK) inhibitors, were recently approved to advance disease management. The emphasis will gradually shift towards personalized medicine that adapts the effectiveness of treatment according to genetic markers.
• China: The market for treating Crohn's disease in China is growing in line with rising awareness and enhanced healthcare systems. Biologic treatments are becoming increasingly available, even though the costs are still quite high for many patients. Companies in the local pharmaceutical industry have been concentrating their efforts on manufacturing biosimilars, a move that should make biologics more accessible and increase patient access to a wider population of patients.
• Germany: Germany has seen an increase in the adoption of biologic treatments and a focus on advanced therapies for Crohn's disease. The government's strong support for healthcare innovation and reimbursement policies ensures that patients have access to the latest therapies. There is also a growing emphasis on telemedicine and remote monitoring to improve patient adherence to treatments.
• India: While in India, the Crohn's disease treatment market is obviously growing, access in certain areas is basically limited to leading-edge therapies. The awareness of Crohn's disease and its treatments is therefore increased, and above all, the government has been implementing policies in favor of improved access to healthcare. The private sector also is expanding the availability of biologics and immunosuppressive drugs.
• Japan: Japan has been expanding its Crohn's disease treatment options, with increasing use of biologics like adalimumab and infliximab. In addition to biologics, Japan has introduced newer oral medications for inflammatory bowel diseases, offering more convenience for patients. The country is also emphasizing the development of precision medicine and the use of genetic testing to guide treatment choices.

Features of the Global Crohn's Disease Treatment Drug Market

• Market Size Estimates: Crohn's disease treatment drug market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Crohn's disease treatment drug market size by type, application, and region in terms of value ($B).
• Regional Analysis: Crohn's disease treatment drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the Crohn's disease treatment drug market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Crohn's disease treatment drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the Crohn's disease treatment drug market by type (aminosalicylates, corticosteroids, immunomodulators, and antibiotics), application (small intestine and large intestine), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Crohn'S Disease Treatment Drug Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Aminosalicylates: Trends and Forecast (2019-2031)
• 4.4 Corticosteroids: Trends and Forecast (2019-2031)
• 4.5 Immunomodulators: Trends and Forecast (2019-2031)
• 4.6 Antibiotics: Trends and Forecast (2019-2031)

5. Global Crohn'S Disease Treatment Drug Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Small Intestine: Trends and Forecast (2019-2031)
• 5.4 Large Intestine: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Crohn'S Disease Treatment Drug Market by Region

7. North American Crohn'S Disease Treatment Drug Market

• 7.1 Overview
• 7.2 North American Crohn'S Disease Treatment Drug Market by Type
• 7.3 North American Crohn'S Disease Treatment Drug Market by Application
• 7.4 United States Crohn'S Disease Treatment Drug Market
• 7.5 Mexican Crohn'S Disease Treatment Drug Market
• 7.6 Canadian Crohn'S Disease Treatment Drug Market

8. European Crohn'S Disease Treatment Drug Market

• 8.1 Overview
• 8.2 European Crohn'S Disease Treatment Drug Market by Type
• 8.3 European Crohn'S Disease Treatment Drug Market by Application
• 8.4 German Crohn'S Disease Treatment Drug Market
• 8.5 French Crohn'S Disease Treatment Drug Market
• 8.6 Spanish Crohn'S Disease Treatment Drug Market
• 8.7 Italian Crohn'S Disease Treatment Drug Market
• 8.8 United Kingdom Crohn'S Disease Treatment Drug Market

9. APAC Crohn'S Disease Treatment Drug Market

• 9.1 Overview
• 9.2 APAC Crohn'S Disease Treatment Drug Market by Type
• 9.3 APAC Crohn'S Disease Treatment Drug Market by Application
• 9.4 Japanese Crohn'S Disease Treatment Drug Market
• 9.5 Indian Crohn'S Disease Treatment Drug Market
• 9.6 Chinese Crohn'S Disease Treatment Drug Market
• 9.7 South Korean Crohn'S Disease Treatment Drug Market
• 9.8 Indonesian Crohn'S Disease Treatment Drug Market

10. ROW Crohn'S Disease Treatment Drug Market

• 10.1 Overview
• 10.2 ROW Crohn'S Disease Treatment Drug Market by Type
• 10.3 ROW Crohn'S Disease Treatment Drug Market by Application
• 10.4 Middle Eastern Crohn'S Disease Treatment Drug Market
• 10.5 South American Crohn'S Disease Treatment Drug Market
• 10.6 African Crohn'S Disease Treatment Drug Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Crohn'S Disease Treatment Drug Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Biogen
  • Company Overview
  • Crohn'S Disease Treatment Drug Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 UCB
  • Company Overview
  • Crohn'S Disease Treatment Drug Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Boehringer
  • Company Overview
  • Crohn'S Disease Treatment Drug Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 AstraZeneca
  • Company Overview
  • Crohn'S Disease Treatment Drug Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 AbbVie
  • Company Overview
  • Crohn'S Disease Treatment Drug Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us